Back to User profile » Dr Meng Zhang
Papers published by Dr Meng Zhang:
Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations
Zhang F, Ge Q, Meng J, Chen J, Liang C, Zhang M
ImmunoTargets and Therapy 2024, 13:111-121
Published Date: 26 February 2024
Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
Zhang M, Liu Y, Chen J, Chen L, Zhang L, Chen X, Hao Z, Liang C
Journal of Inflammation Research 2022, 15:2551-2566
Published Date: 21 April 2022
Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer
Bian Z, Meng J, Niu Q, Jin X, Wang J, Feng X, Che H, Zhou J, Zhang L, Zhang M, Liang C
Cancer Management and Research 2020, 12:8481-8490
Published Date: 15 September 2020
The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients
Zhang P, Zhang M, Han R, Zhang K, Ding H, Liang C, Zhang L
Cancer Management and Research 2018, 10:3371-3381
Published Date: 10 September 2018
Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies
Zhang M, Fang T, Wang K, Mei H, Lv Z, Wang F, Cai Z, Liang C
OncoTargets and Therapy 2016, 9:3727-3737
Published Date: 22 June 2016
Association between two interleukin-2 gene polymorphisms and cancer susceptibility: a meta-analysis
Zhang M, Tan X, Huang J, Xie L, Wang H, Shi J, Lu W, Lv Z, Mei H, Liang C
OncoTargets and Therapy 2016, 9:2181-2192
Published Date: 19 April 2016
Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies
Chen L, Lu W, Fang L, Xiong H, Wu X, Zhang M, Wu S, Yu D
OncoTargets and Therapy 2016, 9:1151-1158
Published Date: 4 March 2016